Evaluating Twitter as a complementary data source for pharmacovigilance.

Jérémy Lardon Florelle BelletRim AboukhamisHadyl AsfariJulien Souvignet Marie-Christine Jaulent Marie-Noëlle Beyens Agnes Lillo Le Louet Cédric Bousquet

Published in: Expert opinion on drug safety (2018)

With the use of dedicated tools, Twitter could become a complementary source of information for pharmacovigilance, despite a major limitation regarding causality assessment of ADRs in individual tweets, which may improve with the new limitation to 280 characters per tweet.

Keyphrases

adverse drug
social media
electronic health record
health information
drug induced
emergency department
big data
healthcare
machine learning
data analysis